Concepedia

Author

Yumiko Shiraishi

Zeria Pharmaceutical (Japan)

Also Known As

Yumiko Shiraishi

3

Publications

75

Citations

3

H-Index

24

Concepts

All Affiliations

Zeria Pharmaceutical (Japan)Central Research Laboratories (United Kingdom)
YS

About

Yumiko Shiraishi is an author at Zeria Pharmaceutical (Japan) specializing in medicine, tumor immunity, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

52

2

Immunology

2

2

52

3

Health Sciences

1

1

28

4

Cell Biology

1

1

24

5

Microbiology

1

1

28

Yumiko Shiraishi

×

3

Publications

75

Citations

3

H-Index

YearCitations

Antimetastatic Effect of an Immunomodulatory Arabinomannan Extracted from Mycobacterium tuberculosis Strain Aoyama B, Z-100, through the Production of Interleukin-12

Hideki Oka, Yumiko Shiraishi, Hidetaka Sasaki,

Biological and Pharmaceutical Bulletin

2003

28

Anti‐Tumor Mechanism of Z‐100, an Immunomodulatory Arabinomannan Extracted from <i>Mycobacterium tuberculosis</i> Strain Aoyama B, on Pulmonary Metastases of B16F10 Melanoma: Restoration of Helper T Cell Responses via Suppression of Glucocorticoid‐Genesis

Hideki Oka, Yutaka Emori, Hidetaka Sasaki,

Microbiology and Immunology

2002

24

Z-100, an Immunomodulatory Arabinomannan Extracted from Mycobacterium tuberculosis Strain Aoyama B, Augments Anti-tumor Activities of X-Ray Irradiation against B16 Melanoma in Association with the Improvement of Type 1T Cell Responses

Hideki Oka, Hidetaka Sasaki, Yumiko Shiraishi,

Biological and Pharmaceutical Bulletin

2004

23

Page 1